Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 1999, p. 1732-1738, Vol. 37, No. 6
Nippon Roche Research Center,
Received 14 September 1998/Returned for modification 15 October
1998/Accepted 16 February 1999
The data on visceral mycoses that had been reported in the
Annual of the Pathological Autopsy Cases in Japan from 1969 to 1994 by the Japanese Society of Pathology were analyzed
epidemiologically. The frequency of visceral mycoses among the annual
total number of pathological autopsy cases increased noticeably from
1.60% in 1969 to a peak of 4.66% in 1990. Among them, the incidences of candidiasis and aspergillosis increased the most. After 1990, however, the frequency of visceral mycoses decreased gradually. Until
1989, the predominant causative agent was Candida, followed in order by Aspergillus and Cryptococcus.
Although the rate of candidiasis decreased by degrees from 1990, the
rate of aspergillosis increased up to and then surpassed that of
candidiasis in 1991. Leukemia was the major disease underlying the
visceral mycoses, followed by solid cancers and other blood and
hematopoietic system diseases. Severe mycotic infection has increased
over the reported 25-year period, from 6.6% of the total visceral
mycosis cases in 1969 to 71% in 1994. The reasons for this decrease of
candidiasis combined with an increase of aspergillosis or of severe
mycotic infection might be that (i) nonsevere (not disseminated)
infections were excluded from the case totals, since they have become
controllable by antifungal drugs such as fluconazole, but (ii) the
available antifungal drugs were not efficacious against severe
infections such as pulmonary aspergillosis, and (iii) the number of
patients living longer in an immunocompromised state had increased
because of developments in chemotherapy and progress in medical care.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Epidemiology of Visceral Mycoses: Analysis of Data
in Annual of the Pathological Autopsy Cases in
Japan
*
Corresponding author. Mailing address: Department of
Mycology, Nippon Roche Research Center, 200 Kajiwara, Kamakura,
Kanagawa 247-8530, Japan. Phone: 81-467-47-2215. Fax: 81-467-46-5320. E-mail: toshikazu.yamazaki{at}roche.com.
Journal of Clinical Microbiology, June 1999, p. 1732-1738, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»